AIMS/HYPOTHESIS: This study aimed to examine the association between diabetes and hyperglycaemia-assessed by HbA(1c)-and change in cognitive function in persons with and without diabetes. METHODS: This was a prospective cohort study of 8,442 non-diabetic and 516 diabetic participants in the Atherosclerosis Risk in Communities (ARIC) study. We examined the association of baseline categories of HbA(1c) with 6 year change in three measures of cognition: the digit symbol substitution test (DSST); the delayed word recall test (DWRT); and the word fluency test (WFT). Our primary outcomes were the quintiles with the greatest annual cognitive decline for each test. Logistic regression models were adjusted for demographic (age, sex, race, field centre, education, income), lifestyle (smoking, drinking) and metabolic (adiposity, blood pressure, cholesterol) factors. RESULTS: The mean age was 56 years. Women accounted for 56% of the study population and 21% of the study population were black. The mean HbA(1c) was 5.7% overall: 8.5% in persons with and 5.5% in persons without diabetes. In adjusted logistic regression models, diagnosed diabetes was associated with cognitive decline on the DSST (OR 1.42, 95% CI 1.14-1.75, p = 0.002), but HbA(1c) was not a significant independent predictor of cognitive decline when stratifying by diabetes diagnosis (diabetes, p trend = 0.320; no diabetes, p trend = 0.566). Trends were not significant for the DWRT or WFT in either the presence or the absence of diabetes. CONCLUSIONS/ INTERPRETATION: Hyperglycaemia, as measured by HbA(1c), did not add predictive power beyond diabetes status for 6 year cognitive decline in this middle-aged population. Additional work is needed to identify the non-glycaemic factors by which diabetes may contribute to cognitive decline.
AIMS/HYPOTHESIS: This study aimed to examine the association between diabetes and hyperglycaemia-assessed by HbA(1c)-and change in cognitive function in persons with and without diabetes. METHODS: This was a prospective cohort study of 8,442 non-diabetic and 516 diabeticparticipants in the Atherosclerosis Risk in Communities (ARIC) study. We examined the association of baseline categories of HbA(1c) with 6 year change in three measures of cognition: the digit symbol substitution test (DSST); the delayed word recall test (DWRT); and the word fluency test (WFT). Our primary outcomes were the quintiles with the greatest annual cognitive decline for each test. Logistic regression models were adjusted for demographic (age, sex, race, field centre, education, income), lifestyle (smoking, drinking) and metabolic (adiposity, blood pressure, cholesterol) factors. RESULTS: The mean age was 56 years. Women accounted for 56% of the study population and 21% of the study population were black. The mean HbA(1c) was 5.7% overall: 8.5% in persons with and 5.5% in persons without diabetes. In adjusted logistic regression models, diagnosed diabetes was associated with cognitive decline on the DSST (OR 1.42, 95% CI 1.14-1.75, p = 0.002), but HbA(1c) was not a significant independent predictor of cognitive decline when stratifying by diabetes diagnosis (diabetes, p trend = 0.320; no diabetes, p trend = 0.566). Trends were not significant for the DWRT or WFT in either the presence or the absence of diabetes. CONCLUSIONS/ INTERPRETATION: Hyperglycaemia, as measured by HbA(1c), did not add predictive power beyond diabetes status for 6 year cognitive decline in this middle-aged population. Additional work is needed to identify the non-glycaemic factors by which diabetes may contribute to cognitive decline.
Authors: Elizabeth Selvin; Josef Coresh; Eyal Shahar; Lin Zhang; Michael Steffes; A Richey Sharrett Journal: Lancet Neurol Date: 2005-12 Impact factor: 44.182
Authors: A R Folsom; M L Rasmussen; L E Chambless; G Howard; L S Cooper; M I Schmidt; G Heiss Journal: Diabetes Care Date: 1999-07 Impact factor: 19.112
Authors: A Alonso; T H Mosley; R F Gottesman; D Catellier; A R Sharrett; J Coresh Journal: J Neurol Neurosurg Psychiatry Date: 2009-08-19 Impact factor: 10.154
Authors: Geert Jan Biessels; Salka Staekenborg; Eric Brunner; Carol Brayne; Philip Scheltens Journal: Lancet Neurol Date: 2006-01 Impact factor: 44.182
Authors: Andreea M Rawlings; A Richey Sharrett; Andrea L C Schneider; Josef Coresh; Marilyn Albert; David Couper; Michael Griswold; Rebecca F Gottesman; Lynne E Wagenknecht; B Gwen Windham; Elizabeth Selvin Journal: Ann Intern Med Date: 2014-12-02 Impact factor: 25.391
Authors: Kristine Yaffe; Cherie Falvey; Nathan Hamilton; Ann V Schwartz; Eleanor M Simonsick; Suzanne Satterfield; Jane A Cauley; Caterina Rosano; Lenore J Launer; Elsa S Strotmeyer; Tamara B Harris Journal: Arch Neurol Date: 2012-09
Authors: Andrea L C Schneider; Rebecca F Gottesman; Thomas Mosley; Alvaro Alonso; David S Knopman; Josef Coresh; A Richey Sharrett; Elizabeth Selvin Journal: Neuroepidemiology Date: 2012-10-22 Impact factor: 3.282
Authors: Jennifer L Dearborn; David Knopman; A Richey Sharrett; Andrea L C Schneider; Clifford R Jack; Laura H Coker; Alvaro Alonso; Elizabeth Selvin; Thomas H Mosley; Lynne E Wagenknecht; Beverly G Windham; Rebecca F Gottesman Journal: Dement Geriatr Cogn Disord Date: 2014-08-20 Impact factor: 2.959
Authors: Kristen M Beavers; Iris Leng; Stephen R Rapp; Michael E Miller; Denise K Houston; Anthony P Marsh; Don G Hire; Laura D Baker; George A Bray; George L Blackburn; Andrea L Hergenroeder; John M Jakicic; Karen C Johnson; Mary T Korytkowski; Brent Van Dorsten; Stephen B Kritchevsky Journal: J Am Geriatr Soc Date: 2016-09-27 Impact factor: 5.562
Authors: Jeannine S Skinner; Amy Morgan; Hector Hernandez-Saucedo; Angela Hansen; Selena Corbett; Matthew Arbuckle; James Ba Leverenz; Consuelo H Wilkins; Suzanne Craft; Laura D Baker Journal: J Gerontol Geriatr Res Date: 2015-07-23